IP Library Granted Patent US 11,160,292
Granted Patent B2
US 11,160,292 · App. 16/559,797 · Granted Nov 2, 2021

Protein-polysaccharide macromolecular complex article of manufacture containing encapsulated ethyl alcohol

Inventors: Margaret Teresa Thomas Virgallito (Beavercreek, OH); Joshua Alan Held (Riverside, CA)
Assignee: Cure Pharmaceutical Holding Corp.
A23G3/42A23G3/44A23P10/30A23L33/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,160,292
App. No.
16/559,797
Granted
Nov 2, 2021
Kind
B2
Abstract

An protein-polysaccharide macromolecular complex article of manufacture containing encapsulated ethyl alcohol and/or other spirits serving as an entertaining and novel non-beverage method of consuming alcohol. The article of manufacture encapsulates ethyl alcohol and/or other spirits in the amorphous regions of the complex macromolecular structure releasing it only upon chewing and exposure to the environment of the oral cavity. The article of manufacture is stable and capable of retaining shape and form for extended periods of time at ambient temperature allowing for relatively low-cost commercial manufacture and distribution.

Claims (20)

1. A protein-polysaccharide macromolecular complex article of manufacture comprising: between 10% and 25% by weight water-soluble protein; between 0.1% and 7.5% by weight water-soluble polysaccharide; and between 60% and 90% by weight ethyl alcohol solution, wherein the ethyl alcohol solution is encapsulated in the macromolecular complex, and wherein said article of manufacture is stable and holds shape and form over a temperature range of 5 degrees to 30 degrees Celsius.

2. An article of manufacture as in claim 1 , wherein said water-soluble polysaccharide is composed of dextrans comprising units linked through alpha (1→6) glucosidic bonds.

3. An article of manufacture as in claim 1 , wherein said water-soluble polysaccharide is composed of dextrans comprising units linked through alternating alpha (1→2), alpha (1→3), and alpha (1→4) glucosidic bonds.

4. An article of manufacture as in claim 1 , wherein said water-soluble polysaccharide is composed of dextrans comprising units linked through consecutive alpha (1→3) glucosidic bonds.

5. An article of manufacture as in claim 1 , wherein said water-soluble polysaccharide is a polysaccharide selected from the group consisting of galactan, iso lichen, laminaran, lavans, pullulan, yeast mannan, and any combination thereof.

6. An article of manufacture as in claim 1 , wherein said water-soluble polysaccharide is pullulan.

7. An article of manufacture as in claim 1 , wherein the water-soluble protein is a vegetable protein.

8. An article of manufacture as in claim 1 , wherein said water soluble protein is an animal protein.

9. An article of manufacture as in claim 1 further comprising between 0.25% and 2.5% by weight of an acidulant.

10. An article of manufacture as in claim 9 , wherein said acidulent is an acidulent selected from a group consisting of tannic acid, lactic acid, ascorbic acid, acetic acid, citric acid, maltic acid, adipic acid, fumaric acid, and any combination thereof.

11. An article of manufacture as in claim 1 further comprising between 0.125% and 2% by weight of a plasticizer.

12. An article of manufacture as in claim 11 , wherein said plasticizer is a plasticizer selected from a group consisting of glycerin, propylene glycol, sorbitol, xylitol, lechitin, medium chain triglycerides, and any combination thereof.

13. A non-beverage article of manufacture for, the article comprising: between 10% and 25% by weight water-soluble protein; between 0.1% and 7.5% by weight water-soluble polysaccharide; and between 60% and 90% by weight non-alcoholic flavor solution, wherein the non-alcoholic flavor solution is encapsulated in a macromolecular complex, and wherein article of manufacture in stable and holds shape and form over a temperature range of 5 degrees to 30 degrees Celsius.

14. An article of manufacture as in claim 13 , wherein said water-soluble polysaccharide is a polysaccharide selected from the group consisting of galactan, isolichen, laminaran, lavans, pullulan, yeast mannan, and any combination thereof.

15. An article of manufacture as in claim 14 , wherein the water-soluble protein is a vegetable protein.

16. An article of manufacture as in claim 14 , wherein said water-soluble protein is an animal protein.

17. An article of manufacture as in claim 14 further comprising between 0.25% and 2.5% by weight of an acidulant.

18. An article of manufacture as in claim 17 , wherein said acidulent is an acidulent selected from a group consisting of tannic acid, lactic acid, ascorbic acid, acetic acid, citric acid, maltic acid, adipic acid, fumaric acid, and any combination thereof.

19. An article of manufacture as in claim 18 further comprising between 0.125% and 2% by weight of a plasticizer.

20. An article of manufacture as in claim 19 , wherein said plasticizer is a plasticizer selected from a group consisting of glycerin, propylene glycol, sorbitol, xylitol, lechitin, medium chain triglycerides, and any combination thereof.

Assignments (5)
LIEN Recorded Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →
CHANGE OF NAME Recorded Jul 17, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064286/0450 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME WHICH SHOULD READ TF TECH VENTURES, INC. AND NOT TF TECH VENTURES PREVIOUSLY RECORDED AT REEL: 060598 FRAME: 0016. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 12, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064256/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES
Reel/Frame 060598/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2022
From: THOMAS VIRGALLITO, MARGARET TERESA; HELD, JOSHUA ALAN
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 059888/0840 →
Continuity (2)
Continuation 13444852 · Apr 12, 2012
Related Publication 20190387767A1 · Dec 26, 2019